Steglujan

Active Ingredient(s): Ertugliflozin + Sitagliptin Phosphate
FDA Approved: * December 19, 2017
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes.[4] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea.[5] It is taken by mouth.[4] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet XR).[4] Common side effects include headaches, swelling of the legs, and upper respiratory... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Steglujan Oral Tablet, Film Coated

NDC: 0006-5367

Labeler:

Merck Sharp & Dohme Corp.

Steglujan Oral Tablet, Film Coated

NDC: 0006-5368

Labeler:

Merck Sharp & Dohme Corp.